Orion Portfolio Solutions LLC Sells 14,210 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Orion Portfolio Solutions LLC reduced its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 246,045 shares of the real estate investment trust's stock after selling 14,210 shares during the quarter. Orion Portfolio Solutions LLC's holdings in Healthpeak Properties were worth $4,987,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in DOC. Bank of Montreal Can acquired a new position in Healthpeak Properties during the 3rd quarter valued at about $19,160,000. The Manufacturers Life Insurance Company bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $13,062,000. D.A. Davidson & CO. purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $2,077,000. FMR LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $67,058,000. Finally, Quantbot Technologies LP bought a new stake in Healthpeak Properties during the third quarter worth $1,753,000. 93.57% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Wells Fargo & Company dropped their price objective on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 10th. Wedbush cut their price target on shares of Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating on the stock in a report on Friday, February 14th. Scotiabank decreased their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research note on Friday, February 28th. Robert W. Baird cut their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research report on Tuesday, February 11th. Finally, Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $23.83.

Remove Ads

Healthpeak Properties Stock Performance

DOC traded down $0.26 on Thursday, hitting $19.80. The company's stock had a trading volume of 1,350,990 shares, compared to its average volume of 4,676,563. Healthpeak Properties, Inc. has a 12 month low of $17.80 and a 12 month high of $23.26. The firm has a market cap of $13.85 billion, a P/E ratio of 56.57, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The company's 50 day simple moving average is $20.18 and its 200-day simple moving average is $21.05.

Healthpeak Properties Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were given a $0.305 dividend. The ex-dividend date was Friday, February 14th. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 6.16%. Healthpeak Properties's payout ratio is 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.